The short version of gastric juice protein fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-24. Anything still debated is marked as such rather than presented as settled.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
| Property | Value | Notes |
|---|---|---|
| Amino acid count | 15 residues | Synthetic pentadecapeptide chain |
| Sequence | GEPPPGKPADDAGLV | Single-letter amino acid code |
| Molecular formula | C62H98N16O22 | Free peptide, without counter-ion |
| Theoretical mass | Approximately 1419.5 daltons | Varies slightly with adducts and counter-ions |
| Origin | Fragment of a human gastric juice protein | Source of the BPC designation |
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
In its usual supplied form, the peptide is a white to off-white lyophilized powder that dissolves readily in water and in aqueous buffers. Powder keeps far longer than solution, so material is normally shipped and stored dry, then dissolved only when needed. Once in solution, the chain is subject to hydrolysis and the liquid supports microbial growth, and practical guidance generally treats the dissolved form as short-lived. Containers should stay sealed and desiccated, because the powder takes up moisture from air.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
The body of the bowfin is elongated and cylindrical, with the sides and back olive to brown in color, often with vertical bars and dark reticulations or another camouflaged pattern. The dorsal fin has horizontal bars, and the caudal fin has irregular, vertical bars. The underside is white or cream, and the paired fins and anal fin are bright green. During larval stage, hatchlings from about 7–10 mm (0.28–0.39 in) total length are black and tadpole-like in appearance. Around 25 mm (0.98 in) total length, they have been described as looking like miniature placoderms. They grow quickly, and typically leave the nest within 4 to 6 weeks after hatching. Young males have a black eyespot on the base of the tail (caudal peduncle) that is commonly encircled by an orange-yellowish border, while the female's is black, if present at all. The purpose of the eyespot thought to be to confuse predators, deflecting attacks away from the head of the fish to its tail, which affords the bowfin an opportunity to escape predation. The bowfin is so named for its long, undulating dorsal fin consisting of 145 to 250 rays that runs from the middle of the back to the base of the tail. The skull of the bowfin is made of two layers, the dermatocranium and the chondrocranium. The chondrocranium layer cannot be seen because it is located below the dermal bones. The bowfin skull is made up of 28 fused bones, which compose the dermatocranium. The roof of the mouth is made up of three bones, the ectopterygoid, the palantine, and the vomer.
Each person carries 2 alleles of each of the 3 class-I genes, (HLA-A, HLA-B and HLA-C), and so can express six different types of MHC-I (see figure). In the class-II locus, each person inherits a pair of HLA-DP genes (DPA1 and DPB1, which encode α and β chains), a couple of genes HLA-DQ (DQA1 and DQB1, for α and β chains), one gene HLA-DRα (DRA1), and one or more genes HLA-DRβ (DRB1 and DRB3, -4 or -5). That means that one heterozygous individual can inherit six or eight functioning class-II alleles, three or more from each parent. The role of DQA2 or DQB2 is not verified. The DRB2, DRB6, DRB7, DRB8 and DRB9 are pseudogenes. The set of alleles that is present in each chromosome is called the MHC haplotype. In humans, each HLA allele is named with a number. For instance, for a given individual, his haplotype might be HLA-A2, HLA-B5, HLA-DR3, etc... Each heterozygous individual will have two MHC haplotypes, one each from the paternal and maternal chromosomes. The MHC genes are highly polymorphic; many different alleles exist in the different individuals inside a population. The polymorphism is so high, in a mixed population (nonendogamic), no two individuals have exactly the same set of MHC molecules, with the exception of identical twins. The polymorphic regions in each allele are located in the region for peptide contact. Of all the peptides that could be displayed by MHC, only a subset will bind strongly enough to any given HLA allele, so by carrying two alleles for each gene, each encoding specificity for unique antigens, a much larger set of peptides can be presented.
The breasts reach full maturity only when a woman's first pregnancy occurs. Changes to the breasts are among the first signs of pregnancy. The breasts become larger, the nipple-areola complex becomes larger and darker, the Montgomery's glands enlarge, and veins sometimes become more visible. Breast tenderness during pregnancy is common, especially during the first trimester. By mid-pregnancy, the breast is physiologically capable of lactation and some women can express colostrum, a form of breast milk. Pregnancy causes elevated levels of the hormone prolactin, which has a key role in the production of milk. However, milk production is blocked by the hormones progesterone and estrogen until after delivery, when progesterone and estrogen levels plummet.
=== Hormonal treatment === D-chiro-inositol has been used to induce ovulation in women with polycystic ovary syndrome. DCI depresses the expression of the steroidogenic enzyme aromatase, which is responsible for the conversion of androgens to estrogens. One pilot study found males taking DCI had increased androgens and reduced estrogen.
Sources: en.wikipedia.org
== Art == The continuity of the deep fasciae within the human body inspired the artistic expression seen in the Fascial Net Plastination Project, which is prominently displayed at the Body Worlds exhibition in Berlin.
== Adverse effects == Various adverse effects may occur according to the pre-workout product and dose of supplement consumed. Some potential side effects of taking pre-workout could include nausea and skin irritation. One ingredient that causes this to happen is beta-alanine. Beta-alanine is commonly included in pre-workouts. It is known to temporarily create an itching sensation on skin. This sensation is harmless. It typically occurs shortly after consumption and is dose dependent. Other adverse effects have been shown to arise when the product contains ingredients such as synephrine and caffeine. Synephrine is often used as a weight loss supplement and commonly found in pre-workout. Synephrine has been found to cause heart problems and other cardiovascular issues. Caffeine is also a common ingredient found in pre-workout which may cause an increase in blood pressure. Another issue that may arise is a higher risk in cardiac and liver related diseases due to the high concentration of caffeine in these types of products.
Frequent lineup changes followed through the rest of the 1970s, and the band broke up in 1982 with Simmons the only constant member having appeared on all of their albums. In 1987, the Doobie Brothers reformed with Johnston back in the fold. McDonald, who made several guest appearances after their reformation, returned full-time in 2019. The group's sixteen studio albums include six top-ten appearances on the Billboard 200 album chart. Their 1978 album Minute by Minute reached number one for five weeks, and won a Grammy for Best Pop Vocal Performance by a Duo or Group. Their song "What a Fool Believes" from that album, written by McDonald and Kenny Loggins, won two Grammys, including Song of the Year and Record of the Year. The band had 16 Billboard Hot 100 top-40 hits, including "Listen to the Music", "Jesus Is Just Alright", "Long Train Runnin'", "China Grove", "Black Water" (#1 in 1974), "Takin' It to the Streets", "What a Fool Believes" (#1 in 1979), and "The Doctor", all of which receive rotation on classic hits radio stations. They have also released six live albums and numerous greatest hits compilations, including 1976's Best of the Doobies, certified diamond by the RIAA for reaching album sales of ten million copies. The Doobie Brothers were inducted into the Vocal Group Hall of Fame in 2004, and the Rock and Roll Hall of Fame in 2020. The group has sold more than 40 million records worldwide.
== Cited literature == Dugan FM. (2011). Conspectus of World Ethnomycology. St. Paul, Minnesota: American Phytopathological Society. ISBN 978-0-89054-395-5. Arora, D. (1986). Mushrooms demystified: A comprehensive guide to the fleshy fungi, Berkeley: Ten Speed Press. pp. 83–103. Kibby, G. & Fatto, R. (1990). Keys to the species of Russula in northeastern North America, Somerville, NJ: Kibby-Fatto Enterprises. 70 pp. Weber, N. S. & Smith, A. H. (1985). A field guide to southern mushrooms, Ann Arbor: U Michigan P. 280 pp. Moser, M. (1978) Basidiomycetes II: Röhrlinge und Blätterpilze, Gustav Fischer Verlag Stuttgart. English edition: Keys to Agarics and Boleti... published by Roger Phillips, London. Partly translated from Dutch page.
=== The technology === This parameter is one of the most undetectable in the Universe due to the fact that solid matter structures are at low temperatures and emit weak radiation. Their luminosity, which is difficult to observe, also makes it impossible to observe them with telescopes. Likewise, we cannot detect them by their gravitational effects. However their existence can be detected by analyzing wavelengths between 8 and 13 microns, corresponding to surface temperatures of 300 K. A hypothetical Dyson sphere could thus be detected, provided that the observation is made from space. Locally, the significant dip in luminosity that would result from a giant Dyson sphere (or "Fermi bubble") would allow the detection of a Type III civilization. A megastructure like a Dyson sphere could be the result of a technology based on self-replicating probes, as those imagined by von Neumann. A Type III civilization would have the means to disperse a significant number of these spheres throughout the galaxy, which would have the effect of attenuating the light emitted by the galaxy. Kaku also considers this to be the most efficient method of colonizing space. For example, a galaxy 100,000 light years in diameter would be explored in half a million years. Paul Davies has suggested that a civilization could colonize the galaxy by scattering miniature probes, no larger than the palm of a hand, using nanotechnology. This thesis is realistic, he explains, because it is obvious that the technology is becoming increasingly miniaturized and proportionally less expensive.
Sources: en.wikipedia.org
Baikiain is an organic compound with the molecular formula C6H9NO2. Chemically, it is classified as a tetrahydropyridine substituted with a carboxylic acid. Because it contains both this carboxylic acid and an adjacent amine group, it is also an alpha-amino acid. Baikiain is one of the two enantiomers of the chiral compound 4,5-didehydropipecolic acid.
== External links == Endoliths General Collection — This collection of online resources such as news articles, web sites, and reference pages provides a comprehensive array of information about endoliths. Endolith Advanced Collection — Compiled for professionals and advanced learners, this endolith collection includes online resources such as journal articles, academic reviews, and surveys.
== Clinical signficance == Many studies have indicated a key role of STAT5a in leukemia, breast, colon, head and neck, and prostate cancer. Until recently, the unique characteristics and function of STAT5a in these cancers have not been delineated from STAT5b, and more research into their differential behavior is warranted. Because of its integral role in immune cell development, STAT5a may contribute to tumor development by compromising immune surveillance. STAT5a expression has been studied closely in prostate and breast cancer, and has only recently shown some promise with colorectal and head and neck cancer. Unphosphorylated or inactive STAT5a may suppress tumor growth in colorectal cancer and active STAT5a expression in premalignant and tumor lesions has shown potential as a prognostic marker in oral squamous cell carcinoma.
1993/1947) Learning for Work (Miscellaneous Provisions) Order 1993 (S.I. 1993/1949) Act of Adjournal (Consolidation Amendment) (Courses for Drink-drive Offenders) 1993 (S.I. 1993/1955) Act of Sederunt (Sheriff Court Ordinary Cause Rules) 1993 (S.I. 1993/1956) Double Taxation Relief (Taxes on Income) (General) (Manufactured Overseas Dividends) Regulations 1993 (S.I. 1993/1957) Dartford–Thurrock Crossing (Amendment) Regulations 1993 (S.I. 1993/1961) Harwich Haven Harbour Revision Order 1993 (S.I. 1993/1962) A4 Trunk Road (Great West Road, Hounslow) (Prescribed Routes) Order 1993 (S.I. 1993/1963) London South Circular Trunk Road (A205) (Westhorne Avenue, Lewisham) (Prohibition of Use of Gaps in Central Reserve) Order 1993 (S.I. 1993/1964) Civil Aviation (Route Charges for Navigation Services) Regulations 1993 (S.I. 1993/1965) Importation of Bovine Semen (Amendment) Regulations 1993 (S.I. 1993/1966) Animals and Animal Products (Import and Export) (Amendment) Regulations 1993 (S.I. 1993/1967) Criminal Justice Act 1993 (Commencement No. 1) Order 1993 (S.I. 1993/1968) Education (Teachers) (Amendment) Regulations 1993 (S.I. 1993/1969) Clyde Port Authority (Dissolution) Order 1993 (S.I. 1993/1970) Education Act 1993 (Commencement No. 1 and Transitional Provisions) Order 1993 (S.I. 1993/1975) Education (London Oratory School) (Exemption from Pay and Conditions Orders) Order 1993 (S.I. 1993/1976) Further Education (Attribution of Surpluses and Deficits) (The Ridge College) Regulations 1993 (S.I.
Sources: en.wikipedia.org
The peptide is synthetic, but its sequence matches a segment of a protein present in human gastric juice. It does not occur as a free fifteen-residue peptide in the body.
Rodents account for the large majority of published experiments. Human data are sparse and mostly observational, so cross-species extrapolation remains uncertain.
It is not an approved therapeutic in most jurisdictions. Regulatory status varies by country, and several places restrict it as a research chemical.
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.